Skip to main content
. 2021 Aug 31;33(4):470–479. doi: 10.21147/j.issn.1000-9604.2021.04.04

Figure 4.

Figure 4

Clinical (A), pathological (B), and molecular (C) parameters associated with engraftment of HCC PDXs. HCC, hepatocellular carcinoma; PDX, patient-derived xenograft; pre-AFP, preoperative level of alpha-fetoprotein.